Violation Tracker UK Individual Case

Company: Accord-UK
Current Parent Company: Intas Pharmaceuticals Ltd.
Penalty: £221,000,000
Year: 2021
Date: 15 July, 2021
Offence Group: competition-related offences
Offence Type: price-fixing or anti-competitive practices
Violation Description: Accord-UK and, for their ownership periods, its parent companies Intas and Accord and its former parent firm Allergan were fined £155 million for charging the NHS excessive and unfair prices for hydrocortisone tablets for almost 10 years, from 2008 to 2018. The CMA also fined Accord-UK and Allergan as former parent a further £66 million for paying two would-be competitors to stay out of the market.
Action Type: agency action
Agency: Competition and Markets Authority
HQ Country of Parent: India
Ownership Structure of Parent: privately held
Major Industry of Parent: pharmaceuticals
Specific Industry of Parent: pharmaceuticals
Source of Data: (click here)